Chopra Daveen
Chopra Daveen, CVP, TMTT, reported a transaction classified as withholding at Edwards Lifesciences Corp involving 1141.000000 shares for an estimated $94429.16. Reported holdings after the transaction were 39779.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 08, 2026
- Filing date
- May 09, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
EW price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001225208-26-005043 Common Stock
- Transaction date
- May 08, 2026 Filed May 09, 2026, 01:16 AM · 1d delay
- Shares
- 1,141 sh $82.76 per share
- Estimated value
- -$94.4k Computed from shares × price
- Holdings after
- 39,779 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
CVP, TMTT & Surgical
- F1
These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable co…
- F2
These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one ye…
- F3
Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Progr…
0 other transactions
0 recent txs